PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332)

Clinical trial NCT03070223 · COMPLETED

Trial details

NCT number: NCT03070223
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV-1 Infection

Start date: 2017-03-14
Primary completion: 2023-08-21
Enrollment: 602

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.